3 Big Pharma Companies May Get a Big Boost From Trump

06/15/18 11:40AM EDT

The Trump administration recently released new details on its plan for drug pricing, which could potentially turn the healthcare industry on its head.

https://youtu.be/RN3n0dAZCAk

Hedgeye Health Policy analyst Emily Evans warns that any changes could potentially take years to implement, but some big pharma companies stand to win big under the Trump plan.

“It took us 50 years to get here. We’re not going to unwind this thing in a few weeks,” Evans explains in the clip above.

“You’re looking at a long trajectory of trying to take 20 to 30 billion dollars out of the system.”

If the changes do go through, Evans thinks it’s good news for companies like Eli Lilly (LLY), Johnson & Johnson (JNJ) and Roche Holdings (RHHBY).

Watch the clip above for more.

3 Big Pharma Companies May Get a Big Boost From Trump - real time alerts

© 2019 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.